Detalles de la búsqueda
1.
Electronic Patient-Reported Outcomes in Hidradenitis Suppurativa: Content Validity and Usability of the Electronic Hidradenitis Suppurativa Symptom Daily Diary, Hidradenitis Suppurativa Symptom Questionnaire, and Hidradenitis Suppurativa Quality of Life Questionnaire.
Dermatology
; 240(1): 65-76, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-37820596
2.
Bimekizumab maintenance of response through 3â years in patients with moderate-to-severe plaque psoriasis: results from the BE BRIGHT open-label extension trial.
Br J Dermatol
; 188(6): 749-759, 2023 05 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36967713
3.
Development and psychometric evaluation of the assessment of self-injection questionnaire: an adaptation of the self-injection assessment questionnaire.
Health Qual Life Outcomes
; 18(1): 355, 2020 Nov 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33148261
4.
Quality of life in patients with ß-thalassemia: A prospective study of transfusion-dependent and non-transfusion-dependent patients in Greece, Italy, Lebanon, and Thailand.
Am J Hematol
; 94(10): E261-E264, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31321793
5.
Burden of Hidradenitis Suppurativa: A Systematic Literature Review of Patient Reported Outcomes.
Dermatol Ther (Heidelb)
; 14(1): 83-98, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38183616
6.
Validity and score interpretation of the 12-item Psoriatic Arthritis Impact of Disease: an analysis of pooled data from two phase 3 trials of bimekizumab in patients with psoriatic arthritis.
RMD Open
; 10(1)2024 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38296802
7.
Validation of the Hidradenitis Suppurativa Investigator Global Assessment: A Novel Hidradenitis Suppurativa-Specific Investigator Global Assessment for Use in Interventional Trials.
JAMA Dermatol
; 159(6): 606-612, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37099284
8.
Psychometric Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM), a Novel Patient-Reported Outcome Instrument for Patients with Plaque Psoriasis, Using Data from the BE VIVID and BE READY Phase 3 Trials.
Dermatol Ther (Heidelb)
; 11(5): 1551-1569, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34260044
9.
Psychometric Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM): A Novel Patient-Reported Outcome Instrument for Patients with Plaque Psoriasis, Using Reported Data from the BE RADIANT Phase 3b Trial.
Adv Ther
; 38(10): 5253-5269, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34471992
10.
Development and Content Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM) for Assessment of Plaque Psoriasis.
Dermatol Ther (Heidelb)
; 10(6): 1255-1272, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32844372
Resultados
1 -
10
de 10
1
Próxima >
>>